Improved high-performance liquid chromatographic analysis of terazosin in human plasma.
暂无分享，去创建一个
[1] S. Law,et al. Adsorption of calcitonin to glass. , 1999, Drug development and industrial pharmacy.
[2] A. Zavitsanos,et al. Enantioselective determination of terazosin in human plasma by normal phase high-performance liquid chromatography-electrospray mass spectrometry. , 1998, Journal of chromatography. A.
[3] M. Michel,et al. Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics. , 1998, British journal of clinical pharmacology.
[4] H. Lepor. Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia* , 1995 .
[5] U. Dunzendorfer,et al. Efficacy of once‐A‐day terazosin in benign prostatic hyperplasia: A randomized, double‐blind placebo‐controlled clinical trial , 1990, The Prostate. Supplement.
[6] H. Lepor,et al. Laboratory assessment of terazosin and alpha-1 blockade in prostatic hyperplasia. , 1988, Urology.
[7] W. Keane,et al. Antihypertensive Therapy with Once‐daily Administration of Terazosin, a New Alpha1‐adrenergic‐receptor Blocker , 1985, Pharmacotherapy.
[8] T. Mizutani. Adsorption of some antibiotics and other drugs on silicone‐coated glass surfaces , 1982, The Journal of pharmacy and pharmacology.
[9] W. Wilson,et al. Problems with iodometric assay of penicillin V benzathine. , 1978, Journal of pharmaceutical sciences.